Pneumocystis jirovecii pneumonia in two patients with systemic lupus erythematosus after rituximab therapy

Clinical Rheumatology

Volumn 33, Issue 3, 2014, Pages 415-418

  Bonilla Abadia F ^a   Betancurt, J F ^b   Pineda, J C ^a   Velez J D ^c   Tobon G J ^a   Canas C A ^a  

^a UNIVERSIDAD ICESI   (Colombia)

^b UNIVERSIDAD CES   (Colombia)

^c FUNDACIÓN VALLE DEL LILI   (Colombia)

Author keywords

Pneumocystis; Pneumocystis jirovecii; Pneumonia; Rituximab; Systemic; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CLINDAMYCIN; COTRIMOXAZOLE; PREDNISONE; PRIMAQUINE; RITUXIMAB;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; BONE MARROW BIOPSY; BRONCHOSCOPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISCOID LUPUS ERYTHEMATOSUS; DRUG USE; FEMALE; HEMOLYTIC ANEMIA; HUMAN; HUMAN TISSUE; LUNG LAVAGE; PERIPHERAL NEUROPATHY; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PULSE OXIMETRY; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; YOUNG ADULT;

ANTI-BACTERIAL AGENTS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; FATAL OUTCOME; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84896495878     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-013-2475-0     Document Type: Article

References (19)

1. Choi J, Kim ST, Craft J (2012) The pathogenesis of systemic lupus erythematosus an update. Curr Opin Immunol 24:651-657
2. Czuczman MS, Weaver R, Alkuzweny B, Berlfein J, Grillo-Lopez AJ (2004) Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up. J Clin Oncol 22:4711-4716
3. Dass S, Vital EM, Emery P (2006) Rituximab: novel B-cell depletion therapy for the treatment of rheumatoid arthritis. Expert Opin Pharmacother 7:2559-2570 (Pubitemid 44932458)
4. Bonilla-Abadía F, Echeverri AF, Izquierdo JH, Cañas F, Cañas CA (2012) Efficacy and safety of rituximab in the treatment of vasculitic leg ulcers associated with hepatitis C virus infection. Case report Rheumatol 2012:923897
5. Garcia-Carrasco M, Mendoza-Pinto C, Sandoval-Cruz M, Soto-Vega E, Beltran-Castillo A, Jimenez-Hernandez M et al (2010) Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients. Lupus 19:213-219
6. Lund FE, Hollifield M, Schuer K, Lines JL, Randall TD, Garvy BA (2006) B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection. J Immunol 176:6147-6154
7. Teichmann LL, Woenckhaus M, Vogel C, Salzberger B, Scholmerich J, Fleck M (2008) Fatal Pneumocystis pneumonia following rituximab administration for rheumatoid arthritis. Rheumatology (Oxford) 47:1256-1257 (Pubitemid 352038242)
8. Hugle B, Solomon M, Harvey E, James A, Wadhwa A et al (2010) Pneumocystis jirovecii pneumonia following rituximab treatment in Wegener's granulomatosis. Arthritis Care Res (Hoboken) 62:1661-1664
9. Tsai MJ, Chou CW, Lin FC, Chang SC (2012) Pneumocystis jirovecii pneumonia in patients with systemic lupus erythematosus after rituximab therapy. Lupus 21:914-918
10. Su GX, Wu FQ, Wang F, Zhou ZX, Huang XL, Lu J (2012) Rituximab therapy for severe pediatric systemic lupus erythematosus. Zhongha Er Ke Za 50:697-704
11. Gigliotti F, Wright TW (2005) Immunopathogenesis of Pneumocystis jirovecii pneumonia. Expert Rev Mol Med 7:1-16
12. Ferreira S, Vasconcelos J, Marinho A, Farinha F, Almeida I et al (2009) CD4 lymphocytopenia in systemic lupus erythematosus. Acta Reumatol Port 34:200-206
13. Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S et al (2008) Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 3:1526-1533
14. Gea-Banacloche JC (2010) Rituximab-associated infections. Semin Hematol 47:187-198
15. Katsuya H, Suzumiya J, Sasaki H, Ishitsuka K, Shibata T et al (2009) Addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy has a high risk of developing interstitial pneumonia in patients with non-Hodgkin lymphoma. Leuk Lymphoma 50:1818-1823
16. Castagnola E, Dallorso S, Faraci M, Morreale G, Di Martino D et al (2003) Long-lasting hypogammaglobulinemia following rituximab administration for Epstein-Barr virus-related post-transplant lymphoproliferative disease preemptive therapy. J Hematother Stem Cell Res 12:9-10 (Pubitemid 36314694)
17. Masur H, Jones TC (1979) The interaction in vitro of Pneumocystis carinii with macrophages and L-cells. J Exp Med 147:157-170
18. Chesnut RW, Grey HM (1982) Antigen presentation by B cells and its significance in TB interactions. Adv Immunol 39:51-94
19. Marcotte H, Levesque D, Delanay K, Bourgeault A, de la Durantaye R et al (1996) Pneumocystis carinii infection in transgenic B cell-deficient mice. J Infect Dis 173:1034-1037 (Pubitemid 26001193)